Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(6.67%),Kynam Capital Management GP, LLC(6.67%), etc.
Feb 14 12:53 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(3.3%),Point72 Capital Advisors, Inc.(3.3%), etc.
Feb 14 07:06 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avidity Partners Management LP(4.7%),Avidity Partners Management (GP) LLC(4.7%), etc.
Feb 13 21:46 ET
Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-The Vanguard Group(5.11%)
Feb 13 17:27 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Metzger Michael A
Feb 9 16:12 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goldan Keith A.
Feb 9 16:12 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gallagher Neil
Feb 9 16:12 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Legault Pierre
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Podlesak Dennis
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Meury William
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Katkin Keith
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jarrett Jennifer
Feb 9 16:06 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Huber Martin H. Jr.
Feb 9 16:06 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(8.94%),Wellington Group Holdings LLP(8.94%), etc.
Feb 8 10:21 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.3%)
Jan 25 17:01 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(5.91%)
Jan 25 11:25 ET
Syndax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Steven A. Cohen(5.1%),Point72 Asset Management, L.P.(4.5%), etc.
Oct 31, 2023 16:26 ET
Syndax Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Frazier Life Sciences Public Fund, L.P.(0.0%),FHMLSP, L.P.(0.0%), etc.
Oct 5, 2023 12:23 ET
Syndax Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Morrison Briggs
Aug 10, 2023 06:50 ET
No Data
No Data